Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial

[1] Grant AD(2005)Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study JAMA 293 2719-2725

[2] Charalambous S(2013)Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial Lancet Infect Dis 13 852-858

[3] Fielding KL(2014)Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial Lancet 384 682-690

[4] Day JH(2014)A trial of mass isoniazid preventive therapy for tuberculosis control N Engl J Med 370 301-310

[5] Corbett EL(2015)A trial of early antiretrovirals and isoniazid preventive therapy in Africa N Engl J Med 373 808-822

[6] Chaisson RE(2019)One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis N Engl J Med 380 1001-1011

[7] Durovni B(2011)Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies PLoS Med 8 e1000391-e28

[8] Saraceni V(2011)Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study PLoS Med 8 e1001067-539

[9] Moulton LH(2012)Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control JAIDS 60 e22-1039

[10] Pacheco AG(2013)Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group protocol A5253 Int J Tuberc Lung Dis 17 532-643

[1] Grant AD(2005)Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study JAMA 293 2719-2725

[2] Charalambous S(2013)Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial Lancet Infect Dis 13 852-858

[3] Fielding KL(2014)Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial Lancet 384 682-690

[4] Day JH(2014)A trial of mass isoniazid preventive therapy for tuberculosis control N Engl J Med 370 301-310

[5] Corbett EL(2015)A trial of early antiretrovirals and isoniazid preventive therapy in Africa N Engl J Med 373 808-822

[6] Chaisson RE(2019)One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis N Engl J Med 380 1001-1011

[7] Durovni B(2011)Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies PLoS Med 8 e1000391-e28

[8] Saraceni V(2011)Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study PLoS Med 8 e1001067-539

[9] Moulton LH(2012)Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control JAIDS 60 e22-1039

[10] Pacheco AG(2013)Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group protocol A5253 Int J Tuberc Lung Dis 17 532-643